Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
about
Patient preference for psychological vs pharmacologic treatment of psychiatric disorders: a meta-analytic reviewIncreasing Access to Cognitive-Behavioural Therapy (CBT) for the Treatment of Mental Illness in Canada: A Research Framework and Call for Action.Delivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.Current Status and Future Prospects of Clinical Psychology: Toward a Scientifically Principled Approach to Mental and Behavioral Health Care.Comparison of psychological placebo and waiting list control conditions in the assessment of cognitive behavioral therapy for the treatment of generalized anxiety disorder: a meta-analysis.Comparing the incomparable? A systematic review of competing techniques for converting descriptive measures of health status into QALY-weights.Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.Management of panic disorder.Treatment of anxiety disorders with venlafaxine XR.Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada.Preventing panic disorder: cost-effectiveness analysis alongside a pragmatic randomised trialImplications of modifying the duration requirement of generalized anxiety disorder in developed and developing countries.Potential of St John's Wort for the treatment of depression: the economic perspective.The cost effectiveness of pharmacological treatments for generalized anxiety disorder.Pharmacological and psychosocial management of mental, neurological and substance use disorders in low- and middle-income countries: issues and current strategies.Empirically supported treatments for panic disorder with agoraphobia in a Spanish psychology clinic.Mental health service use and treatment adequacy for anxiety disorders in Canada.Feasibility of exercise training for the short-term treatment of generalized anxiety disorder: a randomized controlled trial.Dissemination of evidence-based practices for anxiety disorders in Wyoming: a survey of practicing psychotherapists.Occupational functioning, sickness absence and medication utilization before and after cognitive-behaviour therapy for generalized anxiety disorders.[Cognitive-behavioral therapy in panic disorder].The cost-effectiveness of cognitive behavioral therapy for bulimia nervosa in the Australian context.Australia's Better Access initiative: do the evaluation data support the critics?Effectiveness and cost offset analysis of group CBT for hypochondriasis delivered in a psychiatric setting: an open trial.Cost-effectiveness of cognitive-behavioral group therapy for dysfunctional fear of progression in cancer patients.Cost-effectiveness analysis of an occupational therapy-led lifestyle approach and routine general practitioner's care for panic disorder.Computer-aided self-exposure therapy for phobia/panic disorder: a pilot economic evaluation.Evidence-based pharmacological treatment of anxiety disorders, post-traumatic stress disorder and obsessive-compulsive disorder: a revision of the 2005 guidelines from the British Association for Psychopharmacology.Commentary on ‘The role of alprazolam for the treatment of panic disorder in Australia’
P2860
Q27010022-7DBFC5A1-356A-4F01-BE67-E4933B8A964AQ33701842-39D1356C-9C73-42AA-835A-3379717D3240Q34085973-8F564935-18EF-4460-85C9-35E56BC9825CQ34145173-680010E6-6B2A-4D46-BAE9-F615D3AF03F7Q34460845-44E851C7-0934-4AD5-9F4A-F6AC9A08A92CQ34748545-A775B3E8-FB19-404D-BF8E-4567CA430B5FQ36062003-96C11FE3-CA49-42EF-88C2-FC0098D1496DQ36106827-CB612E9C-ECD9-4E3D-874D-3E2B19FC5A7CQ36419538-0D63FF28-7587-407E-AEBE-21563042F9E6Q36628475-1A4A72E6-BF1D-4D0B-A226-BC4EBFC6C266Q37188725-ABA7DCF3-A3DB-4F08-A29F-1ACD0BB9B6BBQ37216651-9623BD0B-6E7F-46F8-8A44-0E01B1A0C509Q37803219-4C6F9735-5C95-46FE-9670-98B80747DCF3Q38091323-69B62B77-570A-4A86-ADBB-BBDAF65E7006Q38133770-B999A543-E79E-445D-AC65-B811D965BD1CQ40858313-9DFB66D8-E60E-4071-8A8D-691D8020A764Q43710281-B5C0D944-F8D1-4895-9576-16CD4031A44CQ44706373-D2C66D7F-3240-4493-A9FB-935A589C880CQ45766424-CA462E7A-E51C-4066-8636-176460A6E2C6Q46153997-BC36AE65-9127-4D55-BD7A-AC1E629C4B21Q46224807-11A030FB-4CE0-4ACA-A075-5DE810A455A4Q47650442-B1166259-0F8E-4E66-A875-BC5561730ED9Q50181412-0FE17B38-56D7-4917-8018-FA13F702FECCQ50661627-3591EBFC-B4F9-4629-9387-B868CD6F4B00Q50674434-5855AFCB-D09D-4A88-9970-4D325A8EF135Q51864593-07C1252D-F5D5-4B31-8C13-E352A608C3EBQ51871191-86ACC1A4-A4A5-4AC1-99A2-387441C1B9CEQ53091817-6655BF59-D66E-45D2-B07C-35E4A8348AE5Q59132895-DB752584-849F-4B2C-9620-390297612714
P2860
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@en
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@nl
type
label
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@en
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@nl
prefLabel
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@en
Cost-effectiveness of psycholo ...... y disorder and panic disorder.
@nl
P2093
P2860
P1476
Cost-effectiveness of psycholo ...... ty disorder and panic disorder
@en
P2093
Gavin Andrews
Louise Heuzenroeder
Marie Donnelly
Rob Carter
Ruth Rossell
P2860
P304
P356
10.1080/J.1440-1614.2004.01423.X
P577
2004-08-01T00:00:00Z